États-Unis · Plateformes & données · The Motley Fool

Twist Bioscience: 3 Key Takeaways for Long-Term Investors

Publié par The Motley Fool · États-Unis il y a 1 h

Résumé détaillé

Twist is expanding from 10 to 16 DNA writers while reinvesting its new profits, a plan that matters for anyone weighing growth against cash generation.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Twist Bioscience: 3 Key Takeaways for Long-Term Investors

Résumé détaillé

À lire aussi

Peraso appoints Kevin Liu as interim CFO

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

SpaceX, Tesla merger talks progress, Bloomberg News reports

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

This Analyst Sees Huang's Resignation As Nvidia CEO As A 'One-Time Clearing Event' For Stock Market

Twist Bioscience: 3 Key Takeaways for Long-Term Investors

Résumé détaillé

Partager

À lire aussi

Peraso appoints Kevin Liu as interim CFO

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

SpaceX, Tesla merger talks progress, Bloomberg News reports

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

This Analyst Sees Huang's Resignation As Nvidia CEO As A 'One-Time Clearing Event' For Stock Market